Clobetasol Propionate 0.05% Ointment Kloderma 10g

Clobetasol Propionate 0.05% Ointment Kloderma 10g

Category

Skin, Medicated Skin

Description
Kloderma 0.05% Ointment is a topical preparation in the form of an ointment containing Clobetasol Propional 0.05%. This medication is used for short-term treatment only for severe inflammatory skin disorders such as recalcitrant eczema unresponsive to less potent corticosteroids, psoriasis.

General Indication
Short-term treatment only for severe inflammatory skin disorders such as recalcitrant eczema that is unresponsive to less potent corticosteroids

Composition
Clobetasol propionate 0.05%

Dose
Apply 1-2 times a day, no more than 50 g applied per week. Up to a maximum of 4 weeks.

How to use
Apply to the affected skin area

Contra Indication
Untreated bacterial, fungal or viral skin lesions, rosacea (acne rosacea) and perioral dermatitis, strong corticosteroids are contraindicated for widespread plaque psoriasis.

Attention
Avoid long-term use of topical corticosteroids on the face because they can leave scars that don't go away (and keep them away from the eyes). In children avoid long-term use and use of strong or very strong corticosteroids should be under the supervision of a specialist. A strong warning is also given to dermatoses in infants including diaper rash, treatment should be limited to 5-7 days. The use of strong and very strong corticosteroids in psoriasis can lead to relapse of the disease, the prevalence of pustular psoriasis and local and systemic toxicity. Pregnancy category: Category C: Possibly at risk. Drugs should be used with caution if the benefits outweigh the risks to the fetus. Animal studies have shown a risk to the fetus and there have been no direct studies in pregnant women. Consult your doctor if you are pregnant and/or breastfeeding.

Side effects
The use of drugs generally has certain side effects and according to each individual. If there are excessive and dangerous side effects, please consult a medical professional. Side effects that may occur in the use of the drug are: Spread and worsening of infection that is not treated. Thinning of the skin that does not necessarily recover after treatment is discontinued because the original structure may not return. Persistent atrophic striae. Contact dermatitis. Perioral dermatitis. Acne, worsening of acne or rosacea. Mild depigmentation, which may be temporary but may persist as white patches. Hypertrichosis.

Segmentation
Red

Packaging
Box, Tube @ 10 gram

Manufacture
Surya Dermato Medica Laboratories

No. Registration
BPOM: DKL8928602030A1